- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-1-1-3-3-mer
- Ligands
- 23 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 3 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA-MAN-MAN.2: 8 residues within 4Å:- Chain C: E.216, L.266, N.267, N.381, R.447, V.449, S.450
- Ligands: NAG.40
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN-MAN.12: 10 residues within 4Å:- Chain E: K.70, E.216, P.217, L.266, N.267, N.381, G.383, C.448, V.449, S.450
1 PLIP interactions:1 interactions with chain E- Hydrogen bonds: E:G.383
NAG-NAG-BMA-MAN-MAN.22: 10 residues within 4Å:- Chain G: E.216, K.257, L.266, N.267, C.382, G.383, R.447, V.449, S.450
- Ligands: NAG.63
2 PLIP interactions:2 interactions with chain G- Hydrophobic interactions: G:V.449
- Hydrogen bonds: G:G.383
- 1 x NAG- NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-6)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 40 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)(Non-covalent)
NAG.28: 3 residues within 4Å:- Chain C: E.92, N.93
- Chain D: S.19
Ligand excluded by PLIPNAG.29: 4 residues within 4Å:- Chain C: C.136, T.137, N.138, N.193
Ligand excluded by PLIPNAG.30: 3 residues within 4Å:- Chain C: S.155, F.156, N.157
Ligand excluded by PLIPNAG.31: 2 residues within 4Å:- Chain C: R.197, N.202
Ligand excluded by PLIPNAG.32: 4 residues within 4Å:- Chain C: N.239, T.241, S.279, H.356
Ligand excluded by PLIPNAG.33: 1 residues within 4Å:- Chain C: N.246
Ligand excluded by PLIPNAG.34: 2 residues within 4Å:- Chain C: N.294, K.348
Ligand excluded by PLIPNAG.35: 3 residues within 4Å:- Chain C: N.306, I.327, V.445
Ligand excluded by PLIPNAG.36: 1 residues within 4Å:- Chain C: N.343
Ligand excluded by PLIPNAG.37: 3 residues within 4Å:- Chain C: N.359, N.360, S.401
Ligand excluded by PLIPNAG.38: 5 residues within 4Å:- Chain C: N.390, S.392
- Ligands: NAG-NAG-NAG.6, NAG-NAG-NAG.6, NAG.39
Ligand excluded by PLIPNAG.39: 2 residues within 4Å:- Chain C: N.396
- Ligands: NAG.38
Ligand excluded by PLIPNAG.40: 4 residues within 4Å:- Chain C: K.257, S.296, N.451
- Ligands: NAG-NAG-BMA-MAN-MAN.2
Ligand excluded by PLIPNAG.41: 2 residues within 4Å:- Chain D: N.102, T.104
Ligand excluded by PLIPNAG.42: 2 residues within 4Å:- Chain D: N.128, Y.129
Ligand excluded by PLIPNAG.43: 3 residues within 4Å:- Chain E: E.92, N.93
- Chain F: S.19
Ligand excluded by PLIPNAG.44: 1 residues within 4Å:- Chain E: N.138
Ligand excluded by PLIPNAG.45: 2 residues within 4Å:- Chain E: N.142, I.327
Ligand excluded by PLIPNAG.46: 3 residues within 4Å:- Chain E: N.281, T.283, N.284
Ligand excluded by PLIPNAG.47: 3 residues within 4Å:- Chain E: N.306, I.327, V.445
Ligand excluded by PLIPNAG.48: 2 residues within 4Å:- Chain E: K.339, N.343
Ligand excluded by PLIPNAG.49: 2 residues within 4Å:- Chain E: N.396
- Ligands: NAG-NAG.17
Ligand excluded by PLIPNAG.50: 2 residues within 4Å:- Chain E: K.355, N.359
Ligand excluded by PLIPNAG.51: 2 residues within 4Å:- Chain F: N.102, T.104
Ligand excluded by PLIPNAG.52: 3 residues within 4Å:- Chain F: N.109, S.111, E.112
Ligand excluded by PLIPNAG.53: 3 residues within 4Å:- Chain F: K.124, E.125, N.128
Ligand excluded by PLIPNAG.54: 2 residues within 4Å:- Chain G: N.138, K.152
Ligand excluded by PLIPNAG.55: 5 residues within 4Å:- Chain A: X.54
- Chain C: R.313
- Chain G: I.181, N.202, T.203
Ligand excluded by PLIPNAG.56: 4 residues within 4Å:- Chain G: Q.135, S.155, F.156, N.157
Ligand excluded by PLIPNAG.57: 4 residues within 4Å:- Chain G: E.273, E.274, N.294, E.295
Ligand excluded by PLIPNAG.58: 3 residues within 4Å:- Chain G: Q.298, N.300, V.449
Ligand excluded by PLIPNAG.59: 2 residues within 4Å:- Chain G: N.306, I.327
Ligand excluded by PLIPNAG.60: 3 residues within 4Å:- Chain G: N.343, W.399, N.402
Ligand excluded by PLIPNAG.61: 4 residues within 4Å:- Chain G: R.354, K.355, G.358, N.359
Ligand excluded by PLIPNAG.62: 3 residues within 4Å:- Chain G: N.396
- Ligands: NAG-NAG.26, NAG-NAG.26
Ligand excluded by PLIPNAG.63: 3 residues within 4Å:- Chain G: S.296, N.451
- Ligands: NAG-NAG-BMA-MAN-MAN.22
Ligand excluded by PLIPNAG.64: 2 residues within 4Å:- Chain H: N.102, T.104
Ligand excluded by PLIPNAG.65: 3 residues within 4Å:- Chain H: N.109, S.111, E.112
Ligand excluded by PLIPNAG.66: 1 residues within 4Å:- Chain H: N.116
Ligand excluded by PLIPNAG.67: 2 residues within 4Å:- Chain H: S.127, N.128
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Brown, S. et al., Anti-immune complex antibodies are elicited during repeated immunization with HIV Env immunogens. Sci Immunol (2025)
- Release Date
- 2025-01-29
- Peptides
- gp120-Interface Polyclonal Antibody - Predicted Heavy Chain: A
gp120-Interface Polyclonal Antibody - Predicted Light Chain: B
Surface protein gp120: CEG
Transmembrane protein gp41: DFH - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
HB
LC
AE
CG
ED
BF
DH
F
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-1-1-3-3-mer
- Ligands
- 23 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 3 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 1 x NAG- NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-6)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 40 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Brown, S. et al., Anti-immune complex antibodies are elicited during repeated immunization with HIV Env immunogens. Sci Immunol (2025)
- Release Date
- 2025-01-29
- Peptides
- gp120-Interface Polyclonal Antibody - Predicted Heavy Chain: A
gp120-Interface Polyclonal Antibody - Predicted Light Chain: B
Surface protein gp120: CEG
Transmembrane protein gp41: DFH - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
HB
LC
AE
CG
ED
BF
DH
F